Filtered news list testing
List of Reports
.pdf
04/21/2022 - Q1 2022 sales
.pdf
04/19/2022 Universal Registration Document 2021
.pdf
04/06/2022 - Guerbet strengthens its Executive Committee with the appointment Of Charlotte Bamière
.pdf
03/29/2022 - Gadopiclenol marketing authorization dossier submissions accepted for review by EMA and FDA
.pdf
03/24/2022 - 2021 Full-year results (Presentation)
.pdf
03/23/2022 - 2021 annual results
.pdf
03/07/2022 - Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization
.pdf
02/10/2022 - 2021 revenue
Single report testing
.pdf
test report fabien V 09-07
Separator
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging